PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSafinamide
Xadago(safinamide)
Safinamide, Xadago (safinamide) is a small molecule pharmaceutical. Safinamide was first approved as Xadago on 2015-02-23. It is used to treat parkinson disease in the USA. It has been approved in Europe to treat parkinson disease. The pharmaceutical is active against amine oxidase [flavin-containing] B.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
Trade Name
FDA
EMA
Safinamide, Xadago (discontinued: Safinamide)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Safinamide mesylate
Tradename
Company
Number
Date
Products
XADAGOMDD US OperationsN-207145 RX2017-03-21
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
xadagoNew Drug Application2024-10-10
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
parkinson diseaseEFO_0002508D010300G20
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Safinamide Mesylate, Xadago, Mdd Us
82833802031-03-21U-1993
80765152028-12-10DS, DPU-1993
82784852027-06-08DPU-1993
ATC Codes
N: Nervous system drugs
— N04: Anti-parkinson drugs
— N04B: Dopaminergic agents
— N04BD: Mao b inhibitors, dopaminergic anti-parkinson drugs
— N04BD03: Safinamide
HCPCS
No data
Clinical
Clinical Trials
27 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Parkinson diseaseD010300EFO_0002508G2014104321
Chronic painD059350—————1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DyskinesiasD020820—G24—11——2
Drug-induced dyskinesiaD004409EFO_1000904———1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Shy-drager syndromeD012791EFO_1001050——1———1
Multiple system atrophyD019578———1———1
AtrophyD001284———1———1
Cognitive dysfunctionD060825—G31.84—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———3————3
Renal insufficiencyD051437—N191————1
Liver diseasesD008107EFO_0001421K70-K771————1
Hepatic insufficiencyD048550——1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSafinamide
INNsafinamide
Description
Safinamide is an amino acid amide.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[C@H](NCc1ccc(OCc2cccc(F)c2)cc1)C(N)=O
Identifiers
PDB—
CAS-ID133865-89-1
RxCUI—
ChEMBL IDCHEMBL396778
ChEBI ID—
PubChem CID131682
DrugBankDB06654
UNII ID90ENL74SIG (ChemIDplus, GSRS)
Target
Agency Approved
MAOB
MAOB
Organism
Homo sapiens
Gene name
MAOB
Gene synonyms
NCBI Gene ID
Protein name
amine oxidase [flavin-containing] B
Protein synonyms
adrenalin oxidase, MAO, brain, MAO, platelet, MAO-B, Monoamine oxidase type B, tyramine oxidase
Uniprot ID
Mouse ortholog
Maob (109731)
amine oxidase [flavin-containing] B (Q8C0B2)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Xadago – Supernus Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,052 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
444 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use